Skip to main content
. 2015 Nov 3;16:496. doi: 10.1186/s13063-015-0990-9

Table 13.

The cost-effectiveness analysis in the 12-month intervention period (the incidence of diabetes)

Group C (yuan) E (%) C/E ΔC/ΔE
The treatment group 21156020.3 16.5 1282183.0 −188775.1
The control group 18815209.0 28.9 651045.3